| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8444207 | European Journal of Cancer | 2013 | 11 Pages |
Abstract
We propose a regular screening of kindreds who have germline mutation. Treatment with imatinib should be considered for those with symptomatic tumour, larger than 3Â cm and/or growing rapidly.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jean-Baptiste Bachet, Bruno Landi, Pierre Laurent-Puig, Antoine Italiano, Axel Le Cesne, Philippe Lévy, Violaine Safar, Florence Duffaud, Jean-Yves Blay, Jean-François Emile,